top of page

​


First autonomous robotic solution for
Mechanical Thrombectomy

HISTORY
Founded in 2017 by Truffle Capital.
Artedrone strives to transform interventional neuroradiology through the introduction of a robotic solution designed for stroke treatments. The primary goal of the company is to enhance accessibility to Mechanical Thrombectomy by minimizing the expertise necessary to carry out the procedure.

Second Cause
of death
worldwide
Third Cause
of
disabilities



High Social
Economic Costs


Poor access to
Standard of Care


bottom of page